{
  "DOI": "10.1002/gepi.22561",
  "ISSN": [
    "0741-0395",
    "1098-2272"
  ],
  "URL": "http://dx.doi.org/10.1002/gepi.22561",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eMultigene panel testing now allows efficient testing of many cancer susceptibility genes leading to a larger number of mutation carriers being identified. They need to be counseled about their cancer risk conferred by the specific gene mutation. An important cancer susceptibility gene is PALB2. Multiple studies reported risk estimates for breast cancer (BC) conferred by pathogenic variants in PALB2. Due to the diverse modalities of reported risk estimates (age‐specific risk, odds ratio, relative risk, and standardized incidence ratio) and effect sizes, a meta‐analysis combining these estimates is necessary to accurately counsel patients with this mutation. However, this is not trivial due to heterogeneity of studies in terms of study design and risk measure. We utilized a recently proposed Bayesian random‐effects meta‐analysis method that can synthesize estimates from such heterogeneous studies. We applied this method to combine estimates from 12 studies on BC risk for carriers of pathogenic PALB2 mutations. The estimated overall (meta‐analysis‐based) risk of BC is 12.80% (6.11%−22.59%) by age 50 and 48.47% (36.05%−61.74%) by age 80. Pathogenic mutations in PALB2 makes women more susceptible to BC. Our risk estimates can help clinically manage patients carrying pathogenic variants in PALB2.\u003c/jats:p\u003e",
  "alternative-id": [
    "10.1002/gepi.22561"
  ],
  "archive": [
    "Portico"
  ],
  "assertion": [
    {
      "group": {
        "label": "Publication History",
        "name": "publication_history"
      },
      "label": "Received",
      "name": "received",
      "order": 0,
      "value": "2023-07-17"
    },
    {
      "group": {
        "label": "Publication History",
        "name": "publication_history"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 1,
      "value": "2024-03-27"
    },
    {
      "group": {
        "label": "Publication History",
        "name": "publication_history"
      },
      "label": "Published",
      "name": "published",
      "order": 2,
      "value": "2024-04-23"
    }
  ],
  "author": [
    {
      "affiliation": [
        {
          "name": "Department of Mathematical Sciences University of Texas at Dallas Richardson USA"
        }
      ],
      "family": "Ruberu",
      "given": "Thanthirige L. M.",
      "sequence": "first"
    },
    {
      "affiliation": [
        {
          "name": "Department of Biostatistics Harvard T.H. Chan School of Public Health Boston USA"
        },
        {
          "name": "Department of Data Science Dana Farber Cancer Institute Boston USA"
        }
      ],
      "family": "Braun",
      "given": "Danielle",
      "sequence": "additional"
    },
    {
      "affiliation": [
        {
          "name": "Department of Biostatistics Harvard T.H. Chan School of Public Health Boston USA"
        },
        {
          "name": "Department of Data Science Dana Farber Cancer Institute Boston USA"
        }
      ],
      "family": "Parmigiani",
      "given": "Giovanni",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-7758-4460",
      "affiliation": [
        {
          "name": "Department of Mathematical Sciences University of Texas at Dallas Richardson USA"
        }
      ],
      "authenticated-orcid": false,
      "family": "Biswas",
      "given": "Swati",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Genetic Epidemiology"
  ],
  "content-domain": {
    "crossmark-restriction": true,
    "domain": [
      "onlinelibrary.wiley.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ],
    "date-time": "2024-04-24T03:39:19Z",
    "timestamp": 1713929959000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        4,
        24
      ]
    ],
    "date-time": "2024-04-24T03:39:40Z",
    "timestamp": 1713929980000
  },
  "funder": [
    {
      "DOI": "10.13039/100000002",
      "doi-asserted-by": "publisher",
      "name": "National Institutes of Health"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        25
      ]
    ],
    "date-time": "2024-04-25T00:28:18Z",
    "timestamp": 1714004898185
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "0741-0395"
    },
    {
      "type": "electronic",
      "value": "1098-2272"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2024,
        4,
        23
      ]
    ]
  },
  "language": "en",
  "license": [
    {
      "URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            4,
            23
          ]
        ],
        "date-time": "2024-04-23T00:00:00Z",
        "timestamp": 1713830400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1002/gepi.22561",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "311",
  "prefix": "10.1002",
  "published": {
    "date-parts": [
      [
        2024,
        4,
        23
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        4,
        23
      ]
    ]
  },
  "publisher": "Wiley",
  "reference": [
    {
      "DOI": "10.1158/1055-9965.EPI-21-1397",
      "article-title": "Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations",
      "author": "Ahearn T. U.",
      "doi-asserted-by": "crossref",
      "first-page": "1593",
      "issue": "8",
      "journal-title": "Cancer Epidemiology, Biomarkers \u0026 Prevention",
      "key": "e_1_2_9_2_1",
      "volume": "31",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.cancergen.2015.06.001",
      "article-title": "Protein‐truncating variants in moderate‐risk breast cancer susceptibility genes: A meta‐analysis of high‐risk case‐control screening studies",
      "author": "Aloraifi F.",
      "doi-asserted-by": "crossref",
      "first-page": "455",
      "issue": "9",
      "journal-title": "Cancer Genetics",
      "key": "e_1_2_9_3_1",
      "volume": "208",
      "year": "2015"
    },
    {
      "DOI": "10.1056/NEJMoa1400382",
      "article-title": "Breast‐cancer risk in families with mutations in PALB2",
      "author": "Antoniou A. C.",
      "doi-asserted-by": "crossref",
      "first-page": "497",
      "issue": "6",
      "journal-title": "New England Journal of Medicine",
      "key": "e_1_2_9_4_1",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s10549-010-1290-4",
      "article-title": "PALB2 mutations in German and Russian patients with bilateral breast cancer",
      "author": "Bogdanova N.",
      "doi-asserted-by": "crossref",
      "first-page": "545",
      "issue": "2",
      "journal-title": "Breast Cancer Research and Treatment",
      "key": "e_1_2_9_5_1",
      "volume": "126",
      "year": "2011"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-10-3958",
      "article-title": "Contribution of inherited mutations in the BRCA2‐ interacting protein PALB2 to familial breast cancer",
      "author": "Casadei S.",
      "doi-asserted-by": "crossref",
      "first-page": "2222",
      "issue": "6",
      "journal-title": "Cancer Research",
      "key": "e_1_2_9_6_1",
      "volume": "71",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S1470-2045(15)70142-7",
      "article-title": "Clinical outcomes in women with breast cancer and a PALB2 mutation: A prospective cohort analysis",
      "author": "Cybulski C.",
      "doi-asserted-by": "crossref",
      "first-page": "638",
      "issue": "6",
      "journal-title": "The Lancet Oncology",
      "key": "e_1_2_9_7_1",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1186/1471-2350-11-20",
      "article-title": "A novel germline PALB2 deletion in Polish breast and ovarian cancer patients",
      "author": "Dansonka‐Mieszkowska A.",
      "doi-asserted-by": "crossref",
      "first-page": "20",
      "issue": "1",
      "journal-title": "BMC Medical Genetics",
      "key": "e_1_2_9_8_1",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1200/CCI.19.00043",
      "article-title": "Validation of a semiautomated natural language processing–based procedure for meta‐analysis of cancer susceptibility gene penetrance",
      "author": "Deng Z.",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "JCO Clinical Cancer Informatics",
      "key": "e_1_2_9_9_1",
      "volume": "3",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.gim.2022.03.015",
      "article-title": "Evaluating breast cancer predisposition genes in women of African ancestry",
      "author": "Díaz‐Zabala H.",
      "doi-asserted-by": "crossref",
      "first-page": "1468",
      "issue": "7",
      "journal-title": "Genetics in Medicine",
      "key": "e_1_2_9_10_1",
      "volume": "24",
      "year": "2022"
    },
    {
      "DOI": "10.1056/NEJMoa1913948",
      "article-title": "Breast cancer risk genes‐association analysis in more than 113,000 women",
      "author": "Dorling L.",
      "doi-asserted-by": "crossref",
      "first-page": "428",
      "issue": "5",
      "journal-title": "New England Journal of Medicine",
      "key": "e_1_2_9_11_1",
      "volume": "384",
      "year": "2021"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-0210",
      "article-title": "Penetrance analysis of the PALB2 c.1592delT founder mutation",
      "author": "Erkko H.",
      "doi-asserted-by": "crossref",
      "first-page": "4667",
      "issue": "14",
      "journal-title": "Clinical Cancer Research",
      "key": "e_1_2_9_12_1",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10549-022-06560-0",
      "article-title": "Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil",
      "author": "Felix G. E. S.",
      "doi-asserted-by": "crossref",
      "first-page": "485",
      "issue": "2",
      "journal-title": "Breast Cancer Research and Treatment",
      "key": "e_1_2_9_13_1",
      "volume": "193",
      "year": "2022"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-3128",
      "article-title": "The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype",
      "author": "Heikkinen T.",
      "doi-asserted-by": "crossref",
      "first-page": "3214",
      "issue": "9",
      "journal-title": "Clinical Cancer Research",
      "key": "e_1_2_9_14_1",
      "volume": "15",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10689-011-9426-1",
      "article-title": "PALB2 mutations in familial breast and pancreatic cancer",
      "author": "Hofstatter E. W.",
      "doi-asserted-by": "crossref",
      "first-page": "225",
      "issue": "2",
      "journal-title": "Familial Cancer",
      "key": "e_1_2_9_15_1",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1126/science.1171202",
      "doi-asserted-by": "publisher",
      "key": "e_1_2_9_16_1"
    },
    {
      "DOI": "10.1086/302808",
      "article-title": "Bias and efficiency in family‐based gene‐characterization studies: Conditional, prospective, retrospective, and joint likelihoods",
      "author": "Kraft P.",
      "doi-asserted-by": "crossref",
      "first-page": "1119",
      "issue": "3",
      "journal-title": "The American Journal of Human Genetics",
      "key": "e_1_2_9_17_1",
      "volume": "66",
      "year": "2000"
    },
    {
      "DOI": "10.1200/PO.16.00066",
      "article-title": "Breast and ovarian cancer penetrance estimates derived from germline multiple‐gene sequencing results in women",
      "author": "Kurian A. W.",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "JCO Precision Oncology",
      "key": "e_1_2_9_18_1",
      "volume": "1",
      "year": "2017"
    },
    {
      "DOI": "10.1093/nar/gkx1153",
      "article-title": "ClinVar: Improving access to variant interpretations and supporting evidence",
      "author": "Landrum M. J.",
      "doi-asserted-by": "crossref",
      "first-page": "D1062",
      "issue": "1",
      "journal-title": "Nucleic Acids Research",
      "key": "e_1_2_9_19_1",
      "volume": "46",
      "year": "2018"
    },
    {
      "DOI": "10.7554/eLife.68699",
      "doi-asserted-by": "publisher",
      "key": "e_1_2_9_20_1"
    },
    {
      "DOI": "10.1002/gepi.21971",
      "article-title": "Penetrance of ATM gene mutations in breast cancer: A meta‐analysis of different measures of risk",
      "author": "Marabelli M.",
      "doi-asserted-by": "crossref",
      "first-page": "425",
      "issue": "5",
      "journal-title": "Genetic Epidemiology",
      "key": "e_1_2_9_21_1",
      "volume": "40",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41467-018-06581-8",
      "article-title": "Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls",
      "author": "Momozawa Y.",
      "doi-asserted-by": "crossref",
      "first-page": "4083",
      "issue": "1",
      "journal-title": "Nature Communications",
      "key": "e_1_2_9_22_1",
      "volume": "9",
      "year": "2018"
    },
    {
      "article-title": "What's new in genetic testing for cancer susceptibility?",
      "author": "Plichta J. K.",
      "first-page": "787",
      "issue": "9",
      "journal-title": "Oncology (Williston Park, NY)",
      "key": "e_1_2_9_23_1",
      "volume": "30",
      "year": "2016"
    },
    {
      "DOI": "10.1515/cclm-2011-0840",
      "article-title": "Hereditary breast cancer: Beyond BRCA genetic analysis; PALB2 emerges",
      "author": "Poumpouridou N.",
      "doi-asserted-by": "crossref",
      "first-page": "423",
      "issue": "3",
      "journal-title": "Clinical Chemistry and Laboratory Medicine",
      "key": "e_1_2_9_24_1",
      "volume": "50",
      "year": "2012"
    },
    {
      "key": "e_1_2_9_25_1",
      "unstructured": "R Core Team.R: A Language and Environment for Statistical Computing;2020. R Foundation for Statistical Computing. https://www.R-project.org/"
    },
    {
      "DOI": "10.1038/ng1959",
      "article-title": "PALB2, which encodes a BRCA2‐interacting protein, is a breast cancer susceptibility gene",
      "author": "Rahman N.",
      "doi-asserted-by": "crossref",
      "first-page": "165",
      "issue": "2",
      "journal-title": "Nature Genetics",
      "key": "e_1_2_9_26_1",
      "volume": "39",
      "year": "2007"
    },
    {
      "key": "e_1_2_9_27_1",
      "unstructured": "Ruberu T. L. M. Braun D. Parmigiani G. \u0026Biswas S.(2024). Bayesian meta‐analysis of penetrance for cancer risk.arXiv. https://doi.org/10.48550/arXiv.2304.01912(To appear in Biometrics)."
    },
    {
      "DOI": "10.1002/cncr.29010",
      "article-title": "Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next‐generation sequencing with a 25‐gene panel",
      "author": "Tung N.",
      "doi-asserted-by": "crossref",
      "first-page": "25",
      "issue": "1",
      "journal-title": "Cancer",
      "key": "e_1_2_9_28_1",
      "volume": "121",
      "year": "2015"
    },
    {
      "DOI": "10.17219/acem/59147",
      "article-title": "The risk of breast cancer due to PALB2 gene mutations",
      "author": "Wesoła M.",
      "doi-asserted-by": "crossref",
      "first-page": "339",
      "issue": "2",
      "journal-title": "Advances in Clinical and Experimental Medicine",
      "key": "e_1_2_9_29_1",
      "volume": "26",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2018.78.3977",
      "article-title": "Inherited breast cancer in Nigerian women",
      "author": "Zheng Y.",
      "doi-asserted-by": "crossref",
      "first-page": "2820",
      "issue": "28",
      "journal-title": "Journal of Clinical Oncology",
      "key": "e_1_2_9_30_1",
      "volume": "36",
      "year": "2018"
    }
  ],
  "reference-count": 29,
  "references-count": 29,
  "resource": {
    "primary": {
      "URL": "https://onlinelibrary.wiley.com/doi/10.1002/gepi.22561"
    }
  },
  "score": 0,
  "short-container-title": [
    "Genetic Epidemiology"
  ],
  "source": "Crossref",
  "title": [
    "Meta‐analysis of breast cancer risk for individuals with PALB2 pathogenic variants"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1002/crossmark_policy"
}